Determining the Role of Social Reward Learning in Social Anhedonia

NCT ID: NCT05617898

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

152 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-14

Study Completion Date

2027-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individuals who recently experienced their first-episode psychosis will be recruited. Participants will be randomized 1:1 to motivational interviewing or a time- and format-matched control probe. At pre- and post-probe, participants will perform two social reward learning tasks in the scanner. With this design feature, we will examine the relationship between sensitivity to social reward and reduced subjective experience of social pleasure at both the behavioral and neural levels.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motivational Interview Intervention

This arm involves three 45-minute sessions on motivational interviewing targeting sensitivity to social reward.

Group Type EXPERIMENTAL

Motivational Interviewing

Intervention Type BEHAVIORAL

Three motivational interviewing sessions will target sensitivity to social reward, including subjective evaluation of social interaction, socially rewarding stimuli, and events (e.g., interactions with others, feedback from others).

Active Control Intervention

This arm involves three 45-minute sessions on didactic training on nutrition.

Group Type ACTIVE_COMPARATOR

Nutrition Didactic Training

Intervention Type BEHAVIORAL

The Nutrition didactic training will ask participants to discuss pros and cons of healthy eating habits and how to improve their current eating habits.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motivational Interviewing

Three motivational interviewing sessions will target sensitivity to social reward, including subjective evaluation of social interaction, socially rewarding stimuli, and events (e.g., interactions with others, feedback from others).

Intervention Type BEHAVIORAL

Nutrition Didactic Training

The Nutrition didactic training will ask participants to discuss pros and cons of healthy eating habits and how to improve their current eating habits.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-35 years
* A first episode of a psychotic illness that began within the past three years
* Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of schizophrenia, schizophreniform, or schizoaffective disorder
* Taking 2nd generation antipsychotic medications
* Estimated premorbid IQ not less than 70 as assessed with the Wechsler Test of Adult Reading
* Appropriate for scanning (i.e., no pacemaker or metal implants) and expressed willingness to participate in scanning
* Sufficient fluency in English to comprehend testing procedures
* Corrected vision of at least 20/30

Exclusion Criteria

* No evidence that substance use makes the diagnosis ambiguous (rule out substance-induced psychosis)
* No evidence of moderate or severe alcohol or substance use disorder in the past 3 months
* No clinically significant disease based on medical history (e.g., epilepsy) or significant head injury
* For females: no current pregnancy
* No sedatives or anxiolytics on the day of assessment
* No medication change 3 weeks prior to enrollment
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Los Angeles

OTHER

Sponsor Role collaborator

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Junghee Lee

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status RECRUITING

University of California Los Angeles

Los Angeles, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Junghee Lee, PhD

Role: CONTACT

205-934-8205

Andrew Meddaugh, BA

Role: CONTACT

205-934-8203

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andrew Meddaugh, BA

Role: primary

205-934-8203

Junghee Lee, PhD

Role: backup

205-934-8205

Rebecca Zornitsky, MS

Role: primary

424-225-1779

Joseph Ventura, PhD

Role: backup

310-206-3142

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01MH129351-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB-300009711

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.